Leishmania chagasi naturally resistant to nitric oxide isolated from humans and dogs with visceral leishmaniasis in Brazil

Nitric Oxide. 2012 Jun 30;27(1):67-71. doi: 10.1016/j.niox.2012.04.004. Epub 2012 Apr 28.

Abstract

Nitric oxide (NO) plays an important role as a leishmanicidal agent in murine macrophages. NO resistant Escherichia coli and Mycobacterium tuberculosis have been associated with poor outcomes of their resulting diseases. NO resistant Leishmania braziliensis has also been identified and exacerbates the clinical course of human leishmaniasis. We report, for the first time, natural resistance of Leishmania chagasi promastigotes to NO. These parasites were isolated from humans and dogs with visceral leishmaniasis. We also demonstrate that this resistance profile was associated with a greater survival capacity and a greater parasite burden in murine macrophages, independent of activation and after activation by IFN-γ and LPS.

MeSH terms

  • Animals
  • Brazil
  • Cell Line
  • Cell Survival / drug effects
  • Dogs
  • Drug Resistance
  • Humans
  • Inhibitory Concentration 50
  • Leishmania / drug effects*
  • Leishmaniasis, Visceral / drug therapy
  • Leishmaniasis, Visceral / parasitology*
  • Leishmaniasis, Visceral / veterinary
  • Life Cycle Stages
  • Macrophages / parasitology
  • Mice
  • Nitric Oxide / pharmacology*
  • Nitric Oxide Donors / pharmacology
  • Parasite Load
  • S-Nitroso-N-Acetylpenicillamine / pharmacology

Substances

  • Nitric Oxide Donors
  • Nitric Oxide
  • S-Nitroso-N-Acetylpenicillamine